Overview

Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX

Status:
Completed

Trial end date:
2013-03-01

Target enrollment:

Participant gender:

Summary

This study is designed to compare the effectiveness of the experimental drug, CP-690,550, to methotrexate in preventing joint damage and improving symptoms of rheumatoid arthritis. This study will also compare the safety of CP-690,550 with methotrexate.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Antirheumatic Agents
Methotrexate
Tofacitinib